The 5’UTR of HCoV-OC43 Adopts a Topologically Constrained Structure to Intrinsically Repress Translation.

For strong mRNA candidates, RNA design must move beyond solely codon optimization and utilize a multiobjective approach.

The Data Catalyst Award helps offset the cost of RNA profiling experiments using Eclipsebio's assays from our RNA profiling portfolio and contributes to the eVERSE database.

Eclipsebio's eCOMPASS platform combines AI-optimized design and sequencing-based analytics to produce successful RNA therapeutics efficiently.

eCOMPASS guides drug developers to the optimal candidate with its lap-in-the-loop platform.